{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:22:05Z","timestamp":1790486525601,"version":"4.1.0"},"reference-count":104,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T00:00:00Z","timestamp":1628553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Primary immune regulatory disorders (PIRD) are associated with autoimmunity, autoinflammation and\/or dysregulation of lymphocyte homeostasis. Autoimmune lymphoproliferative syndrome (ALPS) is a PIRD due to an apoptotic defect in Fas-FasL pathway and characterized by benign and chronic lymphoproliferation, autoimmunity and increased risk of lymphoma. Clinical manifestations and typical laboratory biomarkers of ALPS have also been found in patients with a gene defect out of the Fas-FasL pathway (ALPS-like disorders). Following the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA), we identified more than 600 patients suffering from 24 distinct genetic defects described in the literature with an autoimmune lymphoproliferative phenotype (ALPS-like syndromes) corresponding to phenocopies of primary immunodeficiency (PID) (\n                    <jats:italic>NRAS, KRAS<\/jats:italic>\n                    ), susceptibility to EBV (\n                    <jats:italic>MAGT1, PRKCD, XIAP, SH2D1A, RASGRP1, TNFRSF9<\/jats:italic>\n                    ), antibody deficiency (\n                    <jats:italic>PIK3CD<\/jats:italic>\n                    gain of function (GOF)\n                    <jats:italic>, PIK3R1<\/jats:italic>\n                    loss of function (LOF)\n                    <jats:italic>, CARD11<\/jats:italic>\n                    GOF), regulatory T-cells defects (\n                    <jats:italic>CTLA4, LRBA, STAT3<\/jats:italic>\n                    GOF\n                    <jats:italic>, IL2RA, IL2RB, DEF6<\/jats:italic>\n                    ), combined immunodeficiencies (\n                    <jats:italic>ITK, STK4<\/jats:italic>\n                    ), defects in intrinsic and innate immunity and predisposition to infection (\n                    <jats:italic>STAT1<\/jats:italic>\n                    GOF,\n                    <jats:italic>IL12RB1<\/jats:italic>\n                    ) and autoimmunity\/autoinflammation (\n                    <jats:italic>ADA2, TNFAIP3,TPP2, TET2<\/jats:italic>\n                    ). CTLA4 and LRBA patients correspond around to 50% of total ALPS-like cases. However, only 100% of CTLA4, PRKCD, TET2 and NRAS\/KRAS reported patients had an ALPS-like presentation, while the autoimmunity and lymphoproliferation combination resulted rare in other genetic defects. Recurrent infections, skin lesions, enteropathy and malignancy are the most common clinical manifestations. Some approaches available for the immunological study and identification of ALPS-like patients through flow cytometry and ALPS biomarkers are provided in this work. Protein expression assays for NKG2D, XIAP, SAP, CTLA4 and LRBA deficiencies and functional studies of AKT, STAT1 and STAT3 phosphorylation, are showed as useful tests. Patients suspected to suffer from one of these disorders require rapid and correct diagnosis allowing initiation of tailored specific therapeutic strategies and monitoring thereby improving the prognosis and their quality of life.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2021.671755","type":"journal-article","created":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T00:40:07Z","timestamp":1628556007000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":77,"title":["Primary Immune Regulatory Disorders With an Autoimmune Lymphoproliferative Syndrome-Like Phenotype: Immunologic Evaluation, Early Diagnosis and Management"],"prefix":"10.3389","volume":"12","author":[{"given":"Marta","family":"L\u00f3pez-Nevado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis I.","family":"Gonz\u00e1lez-Granado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Ruiz-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Pleguezuelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Cabrera-Marante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nerea","family":"Salm\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Blanco-Lobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nerea","family":"Dom\u00ednguez-Pinilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca","family":"Rodr\u00edguez-Pena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Sebasti\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Cruz-Rojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Olbrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Ruiz-Contreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estela","family":"Paz-Artal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Neth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis M.","family":"Allende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s10875-019-00737-x","article-title":"Human Inborn Errors of Immunity: 2019 Update on the Classification From the International Union of Immunological Societies Expert Committee","volume":"40","author":"Tangye","year":"2020","journal-title":"J Clin Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s10875-020-00758-x","article-title":"Human Inborn Errors of Immunity: 2019 Update of the IUIS Phenotypical Classification","volume":"40","author":"Bousfiha","year":"2020","journal-title":"J Clin Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00636","article-title":"Evaluating the Genetics of Common Variable Immunodeficiency: Monogenetic Model and Beyond","volume":"9","author":"de Valles-Ib\u00e1\u00f1ez","year":"2018","journal-title":"Front Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20140520","article-title":"Guidelines for Genetic Studies in Single Patients: Lessons From Primary Immunodeficiencies","volume":"211","author":"Casanova","year":"2014","journal-title":"J Exp Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3746","article-title":"Autosomal Dominant Immune Dysregulation Syndrome in Humans With CTLA4 Mutations","volume":"20","author":"Schubert","year":"2014","journal-title":"Nat Med"},{"key":"B6","article-title":"Autoimmunity by Haploinsufficiency","volume-title":"Science","author":"Rieux-Laucat","year":"2014"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(95)90013-6","article-title":"Dominant Interfering Fas Gene Mutations Impair Apoptosis in a Human Autoimmune Lymphoproliferative Syndrome","volume":"81","author":"Fisher","year":"1995","journal-title":"Cell"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1126\/science.7539157","article-title":"Mutations in Fas Associated With Human Lymphoproliferative Syndrome and Autoimmunity","volume":"268","author":"Rieux-Laucat","year":"1995","journal-title":"Sci (80-)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-04-280347","article-title":"Revised Diagnostic Criteria and Classification for the Autoimmune Lymphoproliferative Syndrome (ALPS): Report From the 2009 NIH International Workshop. In: Blood","volume":"116","author":"Oliveira","year":"2010","journal-title":"Blood"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040036","article-title":"Autoimmune Lymphoproliferative Syndrome With Somatic Fas Mutations","volume":"351","author":"Holzelova","year":"2004","journal-title":"N Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-04-015776","article-title":"A Homozygous Fas Ligand Gene Mutation in a Patient Causes a New Type of Autoimmune Lymphoproliferative Syndrome","volume":"108","author":"Del-Rey","year":"2006","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1086\/302333","article-title":"Autoimmune Lymphoproliferative Syndrome With Defective Fas: Genotype Influences Penetrance","volume":"64","author":"Jackson","year":"1999","journal-title":"Am J Hum Genet"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2010.10.028","article-title":"Whole-Exome-Sequencing-Based Discovery of Human FADD Deficiency","volume":"87","author":"Bolze","year":"2010","journal-title":"Am J Hum Genet"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/nature01063","article-title":"Pleiotropic Defects in Lymphocyte Activation Caused by Caspase-8 Mutations Lead to Human Immunodeficiency","volume":"419","author":"Chun","year":"2002","journal-title":"Nature"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2008.11.004","article-title":"Autoimmune Manifestations in Primary Immune Deficiencies","volume":"8","author":"Bussone","year":"2009","journal-title":"Autoimmun Rev Autoimmun Rev"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-019-00677-6","article-title":"A Spectrum of Clinical Findings From ALPS to CVID: Several Novel LRBA Defects","volume":"39","author":"Cagdas","year":"2019","journal-title":"J Clin Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27619","article-title":"Primary Immune Regulatory Disorders for the Pediatric Hematologist and Oncologist: A Case-Based Review","volume":"66","author":"Chandrakasan","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-08-301515","article-title":"Autoimmune Lymphoproliferative Syndrome-Like Disease With Somatic KRAS Mutation","volume":"117","author":"Takagi","year":"2011","journal-title":"Blood"},{"key":"B19","article-title":"ITK Deficiency Presenting as Autoimmune Lymphoproliferative Syndrome","volume":"147","author":"Wallace","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.clim.2015.04.007","article-title":"Autoimmune Lymphoproliferative Syndrome-Like Disease in Patients With LRBA Mutation","volume":"159","author":"Revel-Vilk","year":"2015","journal-title":"Clin Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.jaci.2017.02.032","article-title":"CTLA-4 Haploinsufficiency in a Patient With an Autoimmune Lymphoproliferative Disorder","volume":"140","author":"Kucuk","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02400","article-title":"EBV Negative Lymphoma and Autoimmune Lymphoproliferative Syndrome Like Phenotype Extend the Clinical Spectrum of Primary Immunodeficiency Caused by STK4 Deficiency","volume":"9","author":"Schipp","year":"2018","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.clim.2015.04.015","article-title":"A Case of XMEN Syndrome Presented With Severe Auto-Immune Disorders Mimicking Autoimmune Lymphoproliferative Disease","volume":"159","author":"Patiroglu","year":"2015","journal-title":"Clin Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.clim.2017.05.021","article-title":"STAT3 Gain-of-Function Mutations Associated With Autoimmune Lymphoproliferative Syndrome Like Disease Deregulate Lymphocyte Apoptosis and can be Targeted by BH3 Mimetic Compounds","volume":"181","author":"Nabhani","year":"2017","journal-title":"Clin Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27558","article-title":"Patients With \u201cALPS-Like Phenotype\u201d Diagnosed With Immune Dysregulation Due to LRBA Deficiency","volume":"66","author":"Fern\u00e1ndez","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2014.114967","article-title":"Deregulation of Fas Ligand Expression as a Novel Cause of Autoimmune Lymphoproliferative Syndrome-Like Disease","volume":"100","author":"Nabhani","year":"2015","journal-title":"Haematologica"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020005844","article-title":"Germline TET2 Loss of Function Causes Childhood Immunodeficiency and Lymphoma","volume":"136","author":"Stremenova Spegarova","year":"2020","journal-title":"Blood"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26912","article-title":"Deficiency of ADA2 Mimicking Autoimmune Lymphoproliferative Syndrome in the Absence of Livedo Reticularis and Vasculitis","volume":"65","author":"Alsultan","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1080\/10408363.2020.1855623","article-title":"Immunologic Evaluation and Genetic Defects of Apoptosis in Patients With Autoimmune Lymphoproliferative Syndrome (ALPS)","volume":"58","author":"Casamayor-Polo","year":"2020","journal-title":"Crit Rev Clin Lab Sci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02742","article-title":"Flow Cytometry Contributions for the Diagnosis and Immunopathological Characterization of Primary Immunodeficiency Diseases With Immune Dysregulation","volume":"10","author":"Cabral-Marques","year":"2019","journal-title":"Front Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2019.00353","article-title":"Inborn Errors of Immunity With Immune Dysregulation: From Bench to Bedside","volume":"7","author":"Delmonte","year":"2019","journal-title":"Front Pediatr"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.12688\/f1000research.11545.1","article-title":"Autoimmune Lymphoproliferative Syndrome: More Than a Fascinating Disease","volume":"6","author":"Teachey","year":"2017","journal-title":"F1000Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15178","article-title":"Clinical Features and Therapeutic Challenges of Cytopenias Belonging to Alps and Alps-Related (ARS) Phenotype","volume":"184","author":"Palmisani","year":"2019","journal-title":"Br J Haematol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement","volume":"62","author":"Moher","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"B35","unstructured":""},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-09-3542","article-title":"Unmasking Evans Syndrome: T-Cell Phenotype and Apoptotic Response Reveal Autoimmune Lymphoproliferative Syndrome (ALPS)","volume":"105","author":"Teachey","year":"2005","journal-title":"Blood"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2010.036053","article-title":"New Insights Into Childhood Autoimmune Hemolytic Anemia: A French National Observational Study of 265 Children","volume":"96","author":"Aladjidi","year":"2011","journal-title":"Haematologica"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.25769","article-title":"Combined Autoimmune Cytopenias Presenting in Childhood","volume":"63","author":"Al Ghaithi","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"B39","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.clim.2017.03.004","article-title":"Mutations in PIK3R1 Can Lead to APDS2, SHORT Syndrome or a Combination of the Two","volume":"179","author":"Bravo Garc\u00eda-Morato","year":"2017","journal-title":"Clin Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s10875-019-00688-3","article-title":"Molecular and Phenotypic Characterization of Nine Patients With STAT1 GOF Mutations in China","volume":"40","author":"Chen","year":"2020","journal-title":"J Clin Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12887-015-0522-5","article-title":"The Diagnostic Challenge of Very Early-Onset Enterocolitis in an Infant With XIAP Deficiency","volume":"15","author":"Girardelli","year":"2015","journal-title":"BMC Pediatr"},{"key":"B42","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.201707-1500IM","article-title":"STAT3 Gain of Function: A New Kid on the Block in Interstitial Lung Diseases","volume-title":"American Journal of Respiratory and Critical Care Medicine","author":"Fabre","year":"2018"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-04-570101","article-title":"Autoimmunity, Hypogammaglobulinemia, Lymphoproliferation, and Mycobacterial Disease in Patients With Activating Mutations in STAT3","volume":"125","author":"Haapaniemi","year":"2015","journal-title":"Blood"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20182304","article-title":"Human Interleukin-2 Receptor B Mutations Associated With Defects in Immunity and Peripheral Tolerance","volume":"216","author":"Zhang","year":"2019","journal-title":"J Exp Med"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.jaci.2016.08.042","article-title":"Vedolizumab as a Successful Treatment of CTLA-4\u2013Associated Autoimmune Enterocolitis","volume":"139","author":"Navarini","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B46","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2014-09-602763","article-title":"Early-Onset Lymphoproliferation and Autoimmunity Caused by Germline STAT3 Gain-of-Function Mutations","volume":"125","author":"Milner","year":"2015","journal-title":"Blood"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.09.025","article-title":"The Extended Phenotype of LPS-Responsive Beige-Like Anchor Protein (LRBA) Deficiency","volume":"137","author":"G\u00e1mez-D\u00edaz","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.05.024","article-title":"Cancer in Primary Immunodeficiency Diseases: Cancer Incidence in the United States Immune Deficiency Network Registry","volume":"141","author":"Mayor","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1182\/blood.V98.1.194","article-title":"The Development of Lymphomas in Families With Autoimmune Lymphoproliferative Syndrome With Germline Fas Mutations and Defective Lymphocyte Apoptosis","volume":"98","author":"Straus","year":"2001","journal-title":"Blood"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2017.08.007","article-title":"Combined Immunodeficiency With EBV Positive B Cell Lymphoma and Epidermodysplasia Verruciformis Due to a Novel Homozygous Mutation in RASGRP1","volume":"183","author":"Platt","year":"2017","journal-title":"Clin Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.jaci.2019.03.002","article-title":"Immunodeficiency and EBV-Induced Lymphoproliferation Caused by 4-1BB Deficiency","volume":"144","author":"Alosaimi","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000001487","article-title":"A Rare Case of Activated Phosphoinositide 3-Kinase Delta Syndrome (APDS) Presenting With Hemophagocytosis Complicated With Hodgkin Lymphoma","volume":"42","author":"Cansever","year":"2020","journal-title":"J Pediatr Hematol Oncol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1172\/JCI37901","article-title":"Girls Homozygous for an IL-2-Inducible T Cell Kinase Mutation That Leads to Protein Deficiency Develop Fatal EBV-Associated Lymphoproliferation","volume":"119","author":"Huck","year":"2009","journal-title":"J\u00a0Clin Invest"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2011.371","article-title":"Loss-of-Function Mutations Within the IL-2 Inducible Kinase ITK in Patients With EBV-Associated Lymphoproliferative Diseases","volume":"26","author":"Linka","year":"2012","journal-title":"Leukemia"},{"key":"B55","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2018.02.055","article-title":"Phenotype, Penetrance, and Treatment of 133 Cytotoxic T-Lymphocyte Antigen 4\u2013Insufficient Subjects","volume":"142","author":"Schwab","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2013.01.004","article-title":"Human IL2RA Null Mutation Mediates Immunodeficiency With Lymphoproliferation and Autoimmunity","volume":"146","author":"Goudy","year":"2013","journal-title":"Clin Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"4555","DOI":"10.1038\/s41467-019-12454-5","article-title":"Publisher Correction: Human DEF6 Deficiency Underlies an Immunodeficiency Syndrome With Systemic Autoimmunity and Aberrant CTLA-4 Homeostasis (Nature Communications, (2019), 10, 1, (3106), 10.1038\/s41467-019-10812-x) [Internet]","volume":"10","author":"Serwas","year":"2019","journal-title":"Nat Commun"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1016\/j.jaci.2018.01.012","article-title":"ADA2 Deficiency: Clonal Lymphoproliferation in a Subset of Patients","volume":"141","author":"Trotta","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s10875-014-0106-4","article-title":"Germline CARD11 Mutation in a Patient With Severe Congenital B Cell Lymphocytosis","volume":"35","author":"Brohl","year":"2015","journal-title":"J Clin Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2017.12.009","article-title":"Pediatric-Onset Evans Syndrome: Heterogeneous Presentation and High Frequency of Monogenic Disorders Including LRBA and CTLA4 Mutations","volume":"188","author":"Besnard","year":"2018","journal-title":"Clin Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-08-593202","article-title":"Early-Onset Evans Syndrome, Immunodeficiency, and Premature Immunosenescence Associated With Tripeptidyl-Peptidase II Deficiency. in: Blood","volume":"125","author":"Stepensky","year":"2015","journal-title":"Am Soc Hematol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.09.038","article-title":"Haploinsufficiency of TNFAIP3 (A20) by Germline Mutation is Involved in Autoimmune Lymphoproliferative Syndrome","volume":"139","author":"Takagi","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.24953\/turkjped.2016.03.019","article-title":"Infectious Diseases, Autoimmunity and Midline Defect in a Patient With a Novel Bi-Allelic Mutation in IL12RB1 Gene","volume":"58","author":"G\u00f6kt\u00fcrk","year":"2016","journal-title":"Turk J Pediatr"},{"key":"B64","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.jaci.2012.05.043","article-title":"LPS-Responsive Beige-Like Anchor (LRBA) Gene Mutation in a Family With Inflammatory Bowel Disease and Combined Immunodeficiency","volume":"130","author":"Alangari","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000266","article-title":"Atypical Manifestation of LRBA Deficiency With Predominant IBD-Like Phenotype","volume":"21","author":"Serwas","year":"2015","journal-title":"Inflammation Bowel Dis"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1099\/jmmcr.0.005167","article-title":"Two Male Siblings With a Novel LRBA Mutation Presenting With Different Findings of IPEX Syndrome","volume":"5","author":"Eren Akarcan","year":"2018","journal-title":"JMM Case Rep"},{"key":"B67","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1016\/j.jaip.2019.06.011","article-title":"Abatacept as a Long-Term Targeted Therapy for LRBA Deficiency","volume":"7","author":"Kiykim","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2010.033910","article-title":"IL-2-Inducible T-Cell Kinase Deficiency: Clinical Presentation and Therapeutic Approach","volume":"96","author":"Stepensky","year":"2011","journal-title":"Haematologica"},{"key":"B69","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jaci.2017.10.026","article-title":"RASGRP1 Mutation in Autoimmune Lymphoproliferative Syndrome-Like Disease","volume":"142","author":"Mao","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-017-0377-7","article-title":"Rescue of Cytokine Storm Due to HLH by Hemoadsorption in a CTLA4-Deficient Patient","volume":"37","author":"Greil","year":"2017","journal-title":"J Clin Immunol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01049","article-title":"Clinical, Immunological, and Molecular Findings in Four Cases of B Cell Expansion With NF-\u03bab and T Cell Anergy Disease for the First Time From India","volume":"9","author":"Gupta","year":"2018","journal-title":"Front Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-09-179630","article-title":"FAS-L, IL-10, and Double-Negative CD4 -CD8 - TCR \u03b1\/\u03b2 + T Cells are Reliable Markers of Autoimmune Lymphoproliferative Syndrome (ALPS) Associated With FAS Loss of Function","volume":"113","author":"Magerus-Chatinet","year":"2009","journal-title":"Blood"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020005486","article-title":"Key Diagnostic Markers for Autoimmune Lymphoproliferative Syndrome With Molecular Genetic Diagnosis","volume":"136","author":"Moln\u00e1r","year":"2020","journal-title":"Blood"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2015.12.008","article-title":"The Case of an APDS Patient: Defects in Maturation and Function and Decreased in Vitro Anti-Mycobacterial Activity in the Myeloid Compartment","volume":"178","author":"Chiriaco","year":"2017","journal-title":"Clin Immunol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"e26831","DOI":"10.1002\/pbc.26831","article-title":"Genetic Heterogeneity of Uncharacterized Childhood Autoimmune Diseases With Lymphoproliferation","volume":"65","author":"Takagi","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2017.00049","article-title":"Up, Down, and All Around: Diagnosis and Treatment of Novel STAT3 Variant","volume":"5","author":"Weinreich","year":"2017","journal-title":"Front Pediatr"},{"key":"B77","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s10875-015-0224-7","article-title":"Spectrum of Phenotypes Associated With Mutations in LRBA","volume":"36","author":"Alkhairy","year":"2016","journal-title":"J Clin Immunol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"48","DOI":"10.18176\/jiaci.0205","article-title":"Two Faces of LRBA Deficiency in Siblings: Hypogammaglobulinemia and Normal Immunoglobulin Levels","volume":"28","author":"Azizi","year":"2018","journal-title":"J Investigational Allergol Clin Immunol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1007\/s10875-017-0446-y","article-title":"Multiple Presentations of LRBA Deficiency: A Single-Center Experience","volume":"37","author":"Kostel Bal","year":"2017","journal-title":"J Clin Immunol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.5114\/ceji.2019.89613","article-title":"Development of Multiple Gallstones in a Child With Lipopolysaccharide-Responsive Beige-Like Anchor Protein Mutation","volume":"44","author":"Kutlu\u01e7","year":"2019","journal-title":"Cent Eur J Immunol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000001708","article-title":"Unusual Late-Onset Enteropathy in a Patient With Lipopolysaccharide-Responsive Beige-Like Anchor Protein Deficiency","volume":"42","author":"Maggiore","year":"2020","journal-title":"J Pediatr Hematol Oncol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.jaip.2019.09.027","article-title":"Effective and Safe Treatment of a Novel IL2RA Deficiency With Rapamycin","volume":"8","author":"Lai","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02767\/full","article-title":"ALPS-Like Phenotype Caused by ADA2 Deficiency Rescued by Allogeneic Hematopoietic Stem Cell Transplantation","volume":"9","author":"Barzaghi","year":"2019","journal-title":"Front Immunol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000001132","article-title":"Immune Thrombocytopenia as Key Feature of a Novel ADA2 Deficiency Variant: Implication on Differential Diagnostics of ITP in Children","volume":"41","author":"Sundin","year":"2019","journal-title":"J Pediatr Hematol Oncol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-019-00604-9","article-title":"Novel Heterogeneous Mutation of TNFAIP3 in a Chinese Patient With Beh\u00e7et-Like Phenotype and Persistent EBV Viremia","volume":"39","author":"Dong","year":"2019","journal-title":"J Clin Immunol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-11-567917","article-title":"JMML and RALD (Ras-Associated Autoimmune Leukoproliferative Disorder): Common Genetic Etiology Yet Clinically Distinct Entities","volume":"125","author":"Calvo","year":"2015","journal-title":"Blood"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12986","article-title":"T and B Cell Clonal Expansion in Ras-Associated Lymphoproliferative Disease (RALD) as Revealed by Next-Generation Sequencing","volume":"189","author":"Levy-Mendelovich","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-015-0163-3","article-title":"Somatic Mosaicism for a NRAS Mutation Associates With Disparate Clinical Features in RAS-Associated Leukoproliferative Disease: A Report of Two Cases","volume":"35","author":"Shiota","year":"2015","journal-title":"J Clin Immunol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-07-295501","article-title":"Somatic KRAS Mutations Associated With a Human Nonmalignant Syndrome of Autoimmunity and Abnormal Leukocyte Homeostasis","volume":"117","author":"Niemela","year":"2011","journal-title":"Blood"},{"key":"B90","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.clim.2016.02.002","article-title":"Constant B Cell Lymphocytosis Since Early Age in a Patient With CARD11 Mutation: A 20-Year Follow-Up","volume":"165","author":"Outinen","year":"2016","journal-title":"Clin Immunol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20120831","article-title":"Congenital B Cell Lymphocytosis Explained by Novel Germline CARD11 Mutations","volume":"209","author":"Snow","year":"2012","journal-title":"J Exp Med"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-015-0178-9","article-title":"Potentially Beneficial Effect of Hydroxychloroquine in a Patient With a Novel Mutation in Protein Kinase C\u03b4 Deficiency","volume":"35","author":"Kiykim","year":"2015","journal-title":"J Clin Immunol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-12-469544","article-title":"Loss-of-Function of the Protein Kinase C \u0394 (PKC\u03b4) Causes a B-Cell Lymphoproliferative Syndrome in Humans","volume":"121","author":"Kuehn","year":"2013","journal-title":"Blood"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-020-00746-1","article-title":"The Many Faces of XMEN Disease, Report of Two Patients With Novel Mutations","volume":"40","author":"Hoyos-Bachiloglu","year":"2020","journal-title":"J Clin Immunol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07595.x","article-title":"Treatment With Sirolimus Results in Complete Responses in Patients With Autoimmune Lymphoproliferative Syndrome","volume":"145","author":"Teachey","year":"2009","journal-title":"Br J Haematol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2016.06.058","article-title":"Extending the Clinical Phenotype of Adenosine Deaminase 2 Deficiency","volume":"177","author":"Ben-Ami","year":"2016","journal-title":"J\u00a0Pediatr"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1080\/08820139.2018.1446978","article-title":"Polyautoimmunity in Patients With LPS-Responsive Beige-Like Anchor (LRBA) Deficiency","volume":"47","author":"Azizi","year":"2018","journal-title":"Immunol Invest"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2020000153","article-title":"Treatment of Immune-Mediated Cytopenias in Patients With Primary Immunodeficiencies and Immune Regulatory Disorders (PIRDs)","volume":"20","author":"Seidel","year":"2020","journal-title":"Hematol (United States)"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2019.00295","article-title":"Hematopoietic Stem Cell Transplantation in Primary Immunodeficiency Diseases: Current Status and Future Perspectives","volume":"7","author":"Castagnoli","year":"2019","journal-title":"Front Pediatr"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.jaci.2017.05.022","article-title":"Exaggerated Follicular Helper T-Cell Responses in Patients With LRBA Deficiency Caused by Failure of CTLA4-Mediated Regulation","volume":"141","author":"Alroqi","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01637","article-title":"T Follicular Helper Cells in Autoimmune Disorders","volume":"9","author":"Gensous","year":"2018","journal-title":"Front Immunol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02618","article-title":"Late-Onset Antibody Deficiency Due to Monoallelic Alterations in NFKB1","volume":"10","author":"Schr\u00f6der","year":"2019","journal-title":"Front Immunol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2017.10.012","article-title":"Rag Deficiency With Alps Features Successfully Treated With TCR\u03b1\u03b2\/CD19 Cell Depleted Haploidentical Stem Cell Transplant","volume":"187","author":"Westermann-Clark","year":"2018","journal-title":"Clin Immunol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00297","article-title":"Clinical and Immunological Phenotype of Patients With Primary Immunodeficiency Due to Damaging Mutations in NFKB2","volume":"10","author":"Klemann","year":"2019","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.671755\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T00:40:13Z","timestamp":1628556013000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.671755\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,10]]},"references-count":104,"alternative-id":["10.3389\/fimmu.2021.671755"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.671755","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,10]]},"article-number":"671755"}}